http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-105832722-B
Outgoing Links
| Predicate | Object |
|---|---|
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-381 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-381 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P31-14 |
| filingDate | 2016-04-20-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate | 2019-09-20-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationDate | 2019-09-20-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | CN-105832722-B |
| titleOfInvention | Compound PACMA31 is preparing the application in anti-infection of hepatitis C virus drug |
| abstract | The invention discloses a kind of compound PACMA31 to prepare the application in anti-infection of hepatitis C virus drug.The anti-infection of hepatitis C virus drug is that PACMA31 as sole active agent or includes the pharmaceutical composition of PACMA31.The present invention experiments prove that, PACMA31 can inhibit the infection of Hepatitis C Virus in rna level and protein level, can significantly inhibit HCV invasion target cell.The present invention provides a kind of purposes for preparing anti-hepatitis c virus infection medicine for PACMA31.The present invention provides new source to find anti hepatitis C virus drug. |
| priorityDate | 2016-04-20-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 49.